Cargando…
Successful treatment of schizophrenia with melperone augmentation in a patient with phenotypic CYP2D6 ultrarapid metabolization: a case report
INTRODUCTION: There are limited treatment options for people with schizophrenia with cytochrome P450 2D6 ultrarapid metabolizer status who do not respond to amisulpride. Furthermore, the literature does not provide evidence-based guidelines for this particular constellation. CASE PRESENTATION: We re...
Autores principales: | Gahr, Maximilian, Gastl, Regina, Kölle, Markus A, Schönfeldt-Lecuona, Carlos, Freudenmann, Roland W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298719/ https://www.ncbi.nlm.nih.gov/pubmed/22309430 http://dx.doi.org/10.1186/1752-1947-6-49 |
Ejemplares similares
-
From benzodiazepine to pregabalin dependence: Different agents, similar problems
por: Gahr, Maximilian, et al.
Publicado: (2015) -
Paliperidone extended-release: does it have a place in antipsychotic therapy?
por: Gahr, Maximilian, et al.
Publicado: (2011) -
Retinal single-layer analysis with optical coherence tomography (OCT) in schizophrenia spectrum disorder
por: Kregel, T., et al.
Publicado: (2022) -
Tomophobia, the phobic fear caused by an invasive medical procedure - an emerging anxiety disorder: a case report
por: Schmid, Markus, et al.
Publicado: (2009) -
Auditing Clinical Outcomes after Introducing Off-Licence Prescribing of Atypical Antipsychotic Melperone for Patients with Treatment Refractory Schizophrenia
por: Röhricht, Frank, et al.
Publicado: (2012)